GB1358001A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB1358001A
GB1358001A GB1928372A GB1928372A GB1358001A GB 1358001 A GB1358001 A GB 1358001A GB 1928372 A GB1928372 A GB 1928372A GB 1928372 A GB1928372 A GB 1928372A GB 1358001 A GB1358001 A GB 1358001A
Authority
GB
United Kingdom
Prior art keywords
methaqualone
april
pharmaceutical compositions
drug
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1928372A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SASUCO SA
Original Assignee
SASUCO SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SASUCO SA filed Critical SASUCO SA
Publication of GB1358001A publication Critical patent/GB1358001A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

1358001 Methaqualone-resin complex SASUCO SA 26 April 1972 [26 April 1971] 19283/ 72 Heading A5B [Also in Division C3] The invention comprises methaqualone bound to a copolymer of methacrylic acid and divinylbenzene. The resin preferably has a particle size of 0.5-500Á and about 4% of cross- linkages. In this form the drug is readily released for absorption in the stomach. The drug complex may be combined with a carrier and put up into any conventionel pharmaceutical form.
GB1928372A 1971-04-26 1972-04-26 Pharmaceutical compositions Expired GB1358001A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU63060 1971-04-26

Publications (1)

Publication Number Publication Date
GB1358001A true GB1358001A (en) 1974-06-26

Family

ID=19726690

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1928372A Expired GB1358001A (en) 1971-04-26 1972-04-26 Pharmaceutical compositions

Country Status (6)

Country Link
CH (1) CH540695A (en)
DE (1) DE2220504A1 (en)
FR (1) FR2134503B1 (en)
GB (1) GB1358001A (en)
LU (1) LU63060A1 (en)
NL (1) NL7205573A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007860A1 (en) 1991-10-24 1993-04-29 Kabi Pharmacia Ab New drug formulations with ion-exchangers
US8062667B2 (en) 2006-03-16 2011-11-22 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
US8999386B2 (en) 2012-08-15 2015-04-07 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2355829A1 (en) * 1999-01-07 2000-07-13 Louise Templeton Multiparticulate oral dosage forms

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7017E (en) *
BE560809A (en) *

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007860A1 (en) 1991-10-24 1993-04-29 Kabi Pharmacia Ab New drug formulations with ion-exchangers
US5643560A (en) * 1991-10-24 1997-07-01 Pharmacia & Upjohn Ab Drug formulation with ion-exchangers
US9549989B2 (en) 2006-03-16 2017-01-24 Tris Pharma, Inc Modified release formulations containing drug-ion exchange resin complexes
US10668163B2 (en) 2006-03-16 2020-06-02 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
US9675704B2 (en) 2006-03-16 2017-06-13 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
US8491935B2 (en) 2006-03-16 2013-07-23 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
US8597684B2 (en) 2006-03-16 2013-12-03 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
US8747902B2 (en) 2006-03-16 2014-06-10 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
US8790700B2 (en) 2006-03-16 2014-07-29 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
US8883217B2 (en) 2006-03-16 2014-11-11 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
US8062667B2 (en) 2006-03-16 2011-11-22 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
US10933143B2 (en) 2006-03-16 2021-03-02 Tris Pharma, Inc Modified release formulations containing drug-ion exchange resin complexes
US9198864B2 (en) 2006-03-16 2015-12-01 Tris Pharma, Inc Modified release formulations containing drug-ion exchange resin complexes
US8202537B2 (en) 2006-03-16 2012-06-19 Tris Pharma Inc Modified release formulations containing drug-ion exchange resin complexes
US9522191B2 (en) 2006-03-16 2016-12-20 Tris Pharma, Inc. Modified release formulations containing drug—ion exchange resin complexes
US10172958B2 (en) 2006-03-16 2019-01-08 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
US10086087B2 (en) 2006-03-16 2018-10-02 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
US8337890B2 (en) 2006-03-16 2012-12-25 Tris Pharma Inc Modified release formulations containing drug-ion exchange resin complexes
US9675703B2 (en) 2006-03-16 2017-06-13 Tris Pharma, Inc Modified release formulations containing drug - ion exchange resin complexes
US9295642B2 (en) 2012-08-15 2016-03-29 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
US9844545B2 (en) 2012-08-15 2017-12-19 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
US11633389B2 (en) 2012-08-15 2023-04-25 Tris Pharma, Inc Methylphenidate extended release chewable tablet
US9545399B2 (en) 2012-08-15 2017-01-17 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
US10507203B2 (en) 2012-08-15 2019-12-17 Tris Pharma, Inc Methylphenidate extended release chewable tablet
US9844544B2 (en) 2012-08-15 2017-12-19 Tris Pharma, Inc Methylphenidate extended release chewable tablet
US10857143B2 (en) 2012-08-15 2020-12-08 Tris Pharma, Inc Methylphenidate extended release chewable tablet
US11103494B2 (en) 2012-08-15 2021-08-31 Tris Pharma, Inc Methylphenidate extended release chewable tablet
US11103495B2 (en) 2012-08-15 2021-08-31 Tris Pharma, Inc Methylphenidate extended release chewable tablet
US9180100B2 (en) 2012-08-15 2015-11-10 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
US8999386B2 (en) 2012-08-15 2015-04-07 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets

Also Published As

Publication number Publication date
FR2134503B1 (en) 1976-07-02
DE2220504A1 (en) 1973-02-15
FR2134503A1 (en) 1972-12-08
CH540695A (en) 1973-08-31
NL7205573A (en) 1972-10-30
LU63060A1 (en) 1971-08-26

Similar Documents

Publication Publication Date Title
GB1330878A (en) Ketamine resolution
FI865227A (en) FOERFARANDE FOER FRAMSTAELLNING AV ETT DEPOT-PREPARAT.
IL38571A (en) 5-pyrrolidone-(2)-carboxylic acid esters and their manufacture
GB1358001A (en) Pharmaceutical compositions
IL35564A0 (en) Esters of substituted anthranilic acid,their preparation and pharmaceutical compositions containing them
IL40685A0 (en) Pharmaceutical compositions for the dissolution of renal calculi and their preparation
IL37013A0 (en) Basically substituted alkylidene-aminooxyalkyl carboxylic acid esters,their preparation and pharmaceutical compositions containing them
GB1402691A (en) Composition of 4-biphenyl acetic acid
IL40110A (en) 1-imidazolyl-methanephosphonic acid esters,their production and pharmaceutical compositions containing them
GB1311015A (en) Pharmaceutical compositions and a process for the manufacture thereof
GB1321419A (en) Pharmaceutical composition
IL33937A0 (en) O-chloroalkyl-and o-bromoalkyl-s-benzyl-s'-alkyl-dithiophosphoric acid esters,their preparation and their use as pesticides
GB1254057A (en) Improvements in or relating to therapeutical composition containing vincamine
IL33731A0 (en) O,o-dialkyl-s-(1,2,2-trichloroethyl)-thionothiolphosphoric acid esters and o-alkyl-s-(1,2,2-trichloroethyl)-alkanethionothiolphosphonic acid esters,their preparation and use as insecticides
GB1294538A (en) Pharmaceutical compositions
BE758838A (en) HETEROCYLIC CARBOXYLIC ACID ESTERS AND MEDICINAL PRODUCTS CONTAINING SUCH SUBSTANCES
GB1191554A (en) New Analgesic Composition.
IE34730L (en) Indomethacin suppositories
GB1417817A (en) Substituted acetic acid cyclohexyl esters the preparation thereof and pharmaceutical compositions containing them
ES390407A1 (en) Pharmaceutical tablet
CA967700A (en) In situ process for trans-isomerization and conjugation of resins containing fatty acid esters
CA996572A (en) Process for the preparation of acrylate and methacrylate esters
CA953508A (en) Production of smooth and spheroidal ferrosilicon particles
IL39565A0 (en) The preparation of acid amides and pharmaceutical compositions containing them
Fazio QUANTITATIVE PSYCHOPHARMACOLOGY AND CLINICAL PROBLEMS.

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees